Alembic Pharmaceuticals840.15
-8.60 (-1.01%)

Alembic Pharmaceuticals Share Price

840.15-8.60 (-1.01%)
-12.39% past 1 Year

Corporate filings & documents

Announcements

Please find enclosed Intimation of One to One Investor Meet.
3 days ago
Please find enclosed Intimation of One to One Investor Meet.
3 days ago
Update on USFDA inspection conducted during 3rd March 2025 to 7th March 2025 at Bioequivalence Facility located at Vadodara Gujarat.
5 days ago
Update on USFDA inspection conducted during 3rd March 2025 to 7th March 2025 at Bioequivalence Facility located at Vadodara Gujarat.
5 days ago
Successful completion of unannounced USFDA onsite inspection at Alembic Pharmaceuticals Limiteds Bioequivalence Facility in Vadodara Gujarat.
1 week ago
Successful completion of unannounced USFDA onsite inspection at Alembic Pharmaceuticals Limiteds Bioequivalence Facility in Vadodara Gujarat.
1 week ago
Please find enclosed herewith the Intimation regarding Incorporation of a wholly owned subsidiary company of the Company.
2 weeks ago
Please find enclosed herewith the Intimation regarding Incorporation of a wholly owned subsidiary company of the Company.
2 weeks ago
Please find attached.
3 weeks ago
Please find attached.
3 weeks ago
Please find attached.
3 weeks ago
Please find attached.
3 weeks ago
Please find attached.
4 weeks ago
Please find attached.
4 weeks ago
Intimation regarding Appointment of Company Secretary of the Company.
1 month ago
Intimation regarding Appointment of Company Secretary of the Company.
1 month ago
Please find attached.
1 month ago
Please find attached.
1 month ago
Please find attached.
1 month ago
Please find attached.
1 month ago
Please find attached herewith the Transcript of Post Result Conference Call held on 4th August 2026.
1 month ago
Please find attached herewith the Transcript of Post Result Conference Call held on 4th August 2026.
1 month ago
Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August 2026.
1 month ago
Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August 2026.
1 month ago
Please find attached Proceedings of AGM held on 5th August 2026.
1 month ago
Please find attached Proceedings of AGM held on 5th August 2026.
1 month ago
Please find attached herewith the Newspaper Advertisement.
1 month ago
Please find attached herewith the Newspaper Advertisement.
1 month ago
Please find attached audio recording of investor call.
1 month ago
Please find attached audio recording of investor call.
1 month ago
Please find attached Revised Press Release on Unaudited Financial Results for the quarter ended 30th June 2026.
1 month ago
Please find attached Revised Press Release on Unaudited Financial Results for the quarter ended 30th June 2026.
1 month ago
Please find attached Press Release on Unaudited Financial Results for the quarter ended 30th June 2026.
1 month ago
Please find attached Press Release on Unaudited Financial Results for the quarter ended 30th June 2026.
1 month ago
Please find attached Investor Presentation.
1 month ago
Please find attached Investor Presentation.
1 month ago
Please find attached Unaudited Financial Results for the Quarter ended 30th June 2026.
1 month ago
Please find attached Unaudited Financial Results for the Quarter ended 30th June 2026.
1 month ago
Please find enclosed herewith Outcome of Board Meeting.
1 month ago
Please find enclosed herewith Outcome of Board Meeting.
1 month ago
Alembic Pharmaceuticals Limited receives USFDA Final approval for Prucalopride Tablets 1 mg and 2 mg.
1 month ago
Alembic Pharmaceuticals Limited receives USFDA Final approval for Prucalopride Tablets 1 mg and 2 mg.
1 month ago
Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August 2026.
1 month ago
Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August 2026.
1 month ago
Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2026.
1 month ago
Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2026.
1 month ago
Alembic Pharmaceuticals Limiteds Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets 100 mg and 150 mg
2 months ago
Alembic Pharmaceuticals Limiteds Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets 100 mg and 150 mg
2 months ago
Please find enclosed.
2 months ago
Please find enclosed.
2 months ago

Alembic Pharmaceuticals Ltd Share Price Today

The Alembic Pharmaceuticals Ltd share price today is ₹819.35. During the trading session, the Alembic Pharmaceuticals Ltd share price opened at ₹808.00 and recorded an intraday high of ₹828.10 and a low of ₹804.70. Last closing price was ₹808.20. Over the past 52 weeks, the Alembic Pharmaceuticals Ltd share price has ranged between ₹635.80 and ₹998.00. The current Alembic Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.